Keith Brunt

Keith Brunt, PhD

Dalhousie University/University of New Brunswick

Principal Investigator:

2018 Catalyst Grant Program — Benefit of a Telehealth home-monitoring program for patients living with frailty undergoing heart surgery (CAT 2018-13)


Summer Student Award Recipient 2018 — Michael Connolly

Dr. Keith Brunt is an Associate Professor in the Department of Pharmacology and Medicine at Dalhousie Medicine at the University of New Brunswick, and an Adjunct Professor in the Faculty of Business at the University of New Brunswick. He completed his Honours Bachelor of Science in Physiology at the University of Saskatchewan, and his PhD in Pharmacology (experimental medicine) at Queen’s University. Dr. Brunt completed a post-doctoral fellowship in regenerative medicine at University Health Network in Toronto. In 2012 Dr. Brunt took-up a position at Dalhousie University to establish a new medical school in New Brunswick, which included building a de novo biomedical research program. Dr. Brunt specializes in translational medicine and has an interest in preventing adverse drug events and developing or optimizing pharmacology for special patient groups through fundamental science and applied technologies.Having lived in marginalized communities, published original research, designed and conducted clinical trials and supported research based policy and product commercialization, Dr. Brunt has a diverse portfolio of interests and experiences to share. His current work focuses on improving clinical frailty score utilization, integration with fundamental sciences and improving guidance for medical technology design and adoption for older patients living with frailty, their healthcare team and advocates.